11/30/2022XJTLU and University of Liverpool to Inaugurate Joint Pharma R&D Cente...

11/30/2022Financial-related Company News Digest (November 2022)

11/30/2022Population Ageing in China: Crisis or Opportunity? (The Lancet)

11/30/2022Nowcasting and Forecasting the Care Needs of the Older Population in C...

11/30/2022Chinese Pharma Recovery Face Pressure as Covid Surges to A New Peak

11/29/2022A Slow October Sees Deals in Novel Therapies with New Technologies (Ph...

11/29/2022DB6: Strong Global CHC Growth Continues in MAT Q2/2022, As China Sales...

11/29/2022Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...

11/29/2022Aclaris Therapeutics and Pediatrix Therapeutics Announce License Agree...

11/29/2022Fosun Weighs Sale of Indian Drugmaker Gland Pharma - Bloomberg

11/28/2022CDE Seeks Comments on Draft Chinese Translation of ICH Guidelines Q5A(...

11/28/2022Fosun's Wanbang and Sirona Biochem Sign New Licensing Pact for Non-Ins...

11/28/2022Biocytogen Enters into Antibody Agreement with ADC Therapeutics

11/28/2022Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Pep...

11/28/2022India's API import from China May Fall 25% in the Next Five Years

11/28/2022China Is to Begin Formal Access Negotiation for the 2022 NRDL

11/28/2022Overview of China Drug Review Annual Report (2015-2021)

11/28/2022What Does Biden's Directive on Foreign Biotech Investments Mean for Ma...

11/26/2022CAR-T Therapies See New Competitors Emerge in October (PharmaDJ)

11/25/2022CDE Issues the Technical Guidelines for Bioequivalence Study of Four D...

11/25/2022Drug R&D and Product Registration News Digest November 2022 (4)

11/25/2022Recent Executive Moves

11/25/2022CK Life Sciences Teams Up with XtalPi to Develop Cancer Vaccines

11/24/2022Fosun's Wanbang and Sirona Biochem Sign New Licensing Pact For Non-Ins...

11/24/2022BeyondSpring Receives Nasdaq Notice Regarding Minimum Bid Price Requir...

11/24/2022China Issues the National Action Plan for Containment of Microbiologic...

11/24/2022CDE Issues the Guidelines for General Considerations in Organizing Pat...

11/24/2022CDE Solicits Comments on the Technical Guidelines for Clinical Researc...

11/24/2022IQVIA: Chinese Hospital Drug Market Steady in MAT Q3/2022

11/24/2022Chinese Pharma Companies Won 63 U.S. ANDAs in the First Ten Months of ...

Page:155/810 Total number of articles:24284: [First][<<] [153] [154] [155] [156] [157] [>>] [End]